Mutual Fund Details
NAV
₹20.2960
as on 15 Jan 2021, 10:45 PM
₹-0.2030(0.99%)
Last Change
Schemes Managed By
Start SIP in this Mutual Fund
Min SIP Amount
₹500
Suggested Date
18th of Every Month
Investment Performance
would have given a return of
₹103,499
₹106,749
₹173,161
₹176,119
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹76,119
Profit (absolute return)
76.12%
in the last
1m
3m
1y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
12.10%
In the last 6 months
40.99%
In the last 1 year
76.12%
In the last 3 years
NA
In the last 5 years
NA
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
moderately low
moderate
moderately high
high
Investors understand that their principal will be at high risk
Scheme Information
DSP Healthcare Fund Direct - Growth
as of 31 Dec 2020, 05:30 AM
₹1,043.27 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 12 months.
0.78%
Expense Ratio
Plan
Growth
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 12 months.
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 Dec 2020
Healthcare
94.64%
₹987.35 Cr
Financial
3.52%
₹36.72 Cr
Cash Holding
1.84%
₹19.20 Cr
Companies Holding in this Mutual Fund
as on 31 Dec 2020
Cipla Ltd.
9.28%
₹96.82 Cr
Dr. Reddy's Laboratories Ltd.
8.35%
₹87.11 Cr
Ipca Laboratories Ltd.
8.28%
₹86.38 Cr
Lupin Ltd.
6.82%
₹71.15 Cr
Divi's Laboratories Ltd.
6.19%
₹64.58 Cr
Procter & Gamble Health Ltd.
5.57%
₹58.11 Cr
Sun Pharmaceutical Inds. Ltd.
5.04%
₹52.58 Cr
Apollo Hospitals Enterprise Ltd.
4.87%
₹50.81 Cr
Torrent Pharmaceuticals Ltd.
3.81%
₹39.75 Cr
Max Healthcare Institute Ltd.
3.59%
₹37.45 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 31 Dec 2020
Cipla Ltd.
9.28%
₹96.82 Cr
Dr. Reddy's Laboratories Ltd.
8.35%
₹87.11 Cr
Ipca Laboratories Ltd.
8.28%
₹86.38 Cr
Lupin Ltd.
6.82%
₹71.15 Cr
Divi's Laboratories Ltd.
6.19%
₹64.58 Cr
Procter & Gamble Health Ltd.
5.57%
₹58.11 Cr
Sun Pharmaceutical Inds. Ltd.
5.04%
₹52.58 Cr
Apollo Hospitals Enterprise Ltd.
4.87%
₹50.81 Cr
Torrent Pharmaceuticals Ltd.
3.81%
₹39.75 Cr
Max Healthcare Institute Ltd.
3.59%
₹37.45 Cr
View All
View All
This fund's returns:
76.12%Return Duration
1 Year
Mirae Asset Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹1000
Category Returns
60.39%
81.54%
1Y Returns
71.63
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
60.39%
81.54%
1Y Returns
71.04
Nippon India Pharma Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
60.39%
81.54%
1Y Returns
67.67
SBI Healthcare Opportunities Fund Direct Plan - Growth
EquityPharma
Min. Investment
₹500
Category Returns
60.39%
81.54%
1Y Returns
67.64
UTI Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹500
Category Returns
60.39%
81.54%
1Y Returns
65.94
About DSP Healthcare Fund Direct - Growth
DSP Healthcare Fund Direct - Growth is a Equity mutual fund scheme from DSP Mutual Fund. This scheme was launched on 30 Nov 2018 and is currently managed by its fund managers Vinit Sambre and Chirag Dagli. It has an AUM of ₹1,043.27 Crores and the latest NAV decalared is ₹20.296 as on 17 Jan 2021 at 12:06 am.
DSP Healthcare Fund Direct - Growth scheme return performance in last 1 year is 76.12%, is 101.87% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Details
| AUM: | ₹1,043.27 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | 30 Nov 2018 |
| Fund Type: | Open-End |
Scheme Objective
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
AMC Information
DSP Mutual Fund
View AMC Details
₹95,099.65 Cr
AUM
101
Schemes
Address
NATRAJ, Office No. 302-3rd Floor-Plot No. 194, MV Road JunctionWestern Express Highway,Andheri East400069
Phone Number
Phone : 022-66178000
Fax : 022-56578181
Email / Website
